University of Strathclyde's MSc Cancer Therapies Is Open for 2026: Scholarships Up to Rs. 9.93 Lakh for Indian Students

The University of Strathclyde, Glasgow, has opened applications for its MSc in Cancer Therapies for the September 2026 intake. The course is unique in the UK, the only postgraduate program that combines cancer biology, drug discovery, formulation and delivery, and radiation biology under one curriculum. Alongside admissions, the university is offering Faculty of Science International Excellence Scholarships worth GBP 6,000 to GBP 7,711 (approximately Rs. 7.73 lakh to Rs. 9.93 lakh at 1 GBP = Rs. 128.84, July 22, 2026)  for international students entering in September 2026.

Currency note: 1 GBP = Rs. 128.84 as of July 22, 2026 (BookMyForex/CurrencyWiki mid-market rate). Always verify current rates before financial planning.

About the University of Strathclyde

The University of Strathclyde is a public research university founded in 1796 and located in Glasgow, Scotland. It holds several strong rankings and recognitions:

• Times Higher Education World University Rankings 2026: Top 301-350 globally.
• QS World University Rankings 2027: Ranked #230 globally.
• The Times and Sunday Times Good University Guide 2026: Scottish University of the Year.
• UK Research Excellence Framework (REF 2021): 75% of research rated world-leading or internationally excellent.
• Founded by Professor John Anderson in 1796, the university takes its name from the historic Kingdom of Strathclyde and its motto, 'The Place of Useful Learning,' from Anderson's vision of practical education accessible to all. 

Glasgow itself is Scotland's largest city, with a lower cost of living than London and a growing life sciences and biotech sector. AstraZeneca, GSK, and multiple cancer research institutes have operations in Scotland, creating a genuine employment pipeline for MSc Cancer Therapies graduates.

The MSc Cancer Therapies: What Makes It Unique

The MSc in Cancer Therapies is unique in the UK. It is a multifaceted course and the only one that combines a focus on cancer biology, drug discovery, formulation, and delivery with radiation biology.

This is the distinction that matters for Indian students evaluating options. Most UK oncology-adjacent MSc programs focus on either the biology side (cancer biology, tumor immunology) or the pharmaceutical side (drug delivery, formulation). Strathclyde's program covers both, making graduates uniquely positioned for roles that bridge research and pharmaceutical development.

What the curriculum covers:

Core modules (compulsory):

• Cancer Biology: molecular mechanisms of cancer, genetics, and tumor biology.
• Drug Discovery and Design: from target identification to lead compound development.
• Drug Formulation and Delivery: nanomedicine, drug delivery systems, and clinical translation.
• Radiation Biology: principles of radiotherapy and its clinical applications.
• Personalized Cancer Therapy: practical, ethical, and economic implications.
• Laboratory Classes (two compulsory): biochemistry, pharmacology, microbiology, and immunology research skills with a focus on data analysis and report writing.

Research project: A substantial individual research project conducted in a Strathclyde laboratory, supervised by active cancer researchers. Past projects have included work on seek-and-destroy nanomedicines for prostate cancer, led by Dr. Christine Dufes, and targeted drug delivery systems.

Duration: 12 months full-time (September to September).

Delivery: On-campus in Glasgow. No online option for this program.

The Scholarships

Faculty of Science International Masters Scholarship

Value: GBP 6,000 (approximately Rs. 7,73,040 at 1 GBP = Rs. 128.84).

This is the primary scholarship for international students enrolling in Faculty of Science master's programs, including MSc Cancer Therapies, for the September 2026 intake.

How it is awarded:

• Automatically considered when you apply for admission. No separate scholarship application required.
• Merit-based. Your academic transcripts must demonstrate a high level of achievement, typically a first-class equivalent or strong 2.1.
• The scholarship is deducted directly from your tuition fees.

Eligibility:

• Self-funded international (non-EU) fee-paying students.
• Holding a full-time, on-campus offer for September 2026 entry.
• Cannot be deferred to January 2027.

Faculty of Science International Excellence Scholarships

Value: Rs. 8,69,147 to Rs. 9,93,311 (confirmed from Careers360, April 8, 2026).

These are the higher-value merit awards referenced in the blog topic. The INR range reflects the GBP 6,000 to GBP 7,711 band at the exchange rates prevailing at the time of the announcement.

Important: At the current July 22, 2026 rate of Rs. 128.84, GBP 6,000 converts to Rs. 7,73,040 and GBP 7,711 converts to Rs. 9,93,380. The scholarship values in INR fluctuate with the exchange rate. Budget using the GBP value, not the INR headline.

How to apply: No separate form is required for most Faculty of Science awards. Apply for the MSc Cancer Therapies program at strath.ac.uk, and eligible applicants are automatically considered.

Eligibility: Who Can Apply

Academic qualifications:

• Minimum second-class (2.2) honors degree or international equivalent in a science or health-related subject.
• For Indian students: this broadly equates to approximately 55% aggregate or above in BSc or BPharm.
• Students with a 2.2 equivalent (55% to 60% aggregate) are eligible, but more competitive applications typically come from first-class or strong 2.1 equivalents (65%+).

Alternative entry: Students with alternative entry standards or professional experience may be considered and are usually admitted initially to the diploma course. Upon satisfactory completion of Semester 1 assessments, these students are offered the opportunity to transfer to the full MSc.

English language requirements:

• IELTS Academic: 6.5 overall with no component below 6.0.
• TOEFL iBT: 90 overall.

The MSc is designed for graduates from BSc Biology, Biochemistry, Pharmacy, Pharmaceutical Sciences, Biomedical Sciences, or related health science fields. Students from medicine or nursing backgrounds with research interests in oncology may also be considered under the alternative entry route.

Tuition Fees and Total Cost

Tuition fees (2026-27, international students): Approximately GBP 24,650/year (approximately Rs. 31,75,538 at 1 GBP = Rs. 128.84).

After the GBP 6,000 scholarship: Approximately GBP 18,650 (approximately Rs. 24,02,638/year).

Living costs in Glasgow per year:

• Accommodation: GBP 5,000 to GBP 9,000/year (approximately Rs. 6.44 lakh to Rs. 11.60 lakh).
• Food, transport, and personal expenses: approximately GBP 5,000 to GBP 7,000/year (approximately Rs. 6.44 lakh to Rs. 9.02 lakh).
• Total living costs: approximately GBP 10,000 to GBP 16,000/year (approximately Rs. 12.88 lakh to Rs. 20.61 lakh).

Glasgow is consistently among the most affordable major UK university cities for international students, significantly cheaper than London, Bristol, or Edinburgh. The NHS Scotland free prescription policy also applies to students registered with a Glasgow GP.

Total cost for the 12-month MSc (post-scholarship): Approximately GBP 28,650 to GBP 34,650 (approximately Rs. 36.91 lakh to Rs. 44.64 lakh).

Career Outcomes: Where This MSc Leads

The global cancer therapeutics market is projected to exceed USD 400 billion by 2030. India's own oncology sector is one of the fastest growing in healthcare, driven by rising cancer incidence, expanding private hospital chains, and a growing domestic pharmaceutical R&D pipeline.

Graduates of the MSc Cancer Therapies at Strathclyde have gone on to the following:

• Roles in pharmaceutical and biotech companies in cancer drug development and clinical trials.
• Research positions at cancer institutes and NHS Scotland trusts.
• PhD programs at UK and EU universities.
• Regulatory affairs and medical science liaison roles in oncology-focused MNCs.
• Academic and research positions in India at institutions including AIIMS, TMC, ACTREC, and pharmaceutical majors.

For Indian students specifically, an MSc in Cancer Therapies from a UK university combined with 1 to 2 years of graduate-route work experience in the UK life sciences sector positions graduates for senior research and regulatory roles in India's pharmaceutical and oncology sectors at significantly higher entry points than domestic graduates have.

How to Apply

Applications are submitted online at strath.ac.uk. The university accepts applications on a rolling basis. There is no fixed closing date published for MSc Cancer Therapies for September 2026, but places fill as applications are reviewed.

Application requirements:

• Online application form.
• Academic transcripts and degree certificate.
• Personal statement addressing your interest in cancer therapies and career goals.
• Two academic or professional references.
• English language test scores (IELTS/TOEFL).
• CV or résumé.

Post-study work: The UK Graduate Route visa is 2 years for applications submitted before January 1, 2027. Strathclyde MSc Cancer Therapies graduates qualify for the Graduate Route on completion, giving them 2 years to work in any UK role, including research, pharmaceutical, and clinical trial management, before needing a Skilled Worker sponsor.

Book a free session with a Leap Scholar counselor to understand whether the Strathclyde MSc Cancer Therapies fits your academic background and career goals, how to maximize your scholarship eligibility, and what the full financial and visa picture looks like for Indian students applying to this program.

Sources: Strathclyde Official, MSc Cancer Therapies | Strathclyde Official, International Scholarships | Currency.Wiki, GBP to INR July 22, 2026 | QS 2027 rankings